Examination of the reduction chemistry of Nd-(NR 2 ) 3 (R = SiMe 3 ) under N 2 has provided connections between the in situ Ln(III)-based Ln III (NR 2 ) 3 /K reductions of N 2 that form side-on bound neutral (N=N) 2− complexes, [(R 2 N) 2 (THF)-Ln] 2 [μ-η 2 :η 2 -N 2 ], and the Ln(II)-based [Ln II (NR 2 ) 3 ] 1− reductions by Sc, Gd, and Tb that form end-on bound (N=N) 2− complexes, {[(R 2 N) 3 Ln] 2 [μ-η 1 :η 1 -N 2 ]} 2− , which are dianions. The reduction of Nd(NR 2 ) 3 by KC 8 under dinitrogen in Et 2 O in the presence of 18-crown-6 (18-c-6) forms dark yellow solutions of [K 2 (18-c-6) 3 ]{[(R 2 N) 3 Nd] 2 N 2 } at low temperatures that become green as they warm up to −35 °C in a glovebox freezer. Green crystals obtained from the solution turn yellow-brown when cooled below −100 °C, and the yellow-brown compound has an end-on Nd 2 (μ-η 1 :η 1 -N 2 ) structure. The yellow-brown crystals isomerize in the solid state on the diffractometer upon warming, and at −25 °C, the crystals are green and have a side-on Nd 2 (μ-η 2 :η 2 -N 2 ) structure.Collection of X-ray diffraction data at 10 °C intervals from −50 to −90 °C revealed that the isomerization occurs at temperatures below −100 °C. In the presence of tetrahydrofuran (THF), the dianionic {[(R 2 N) 3 Nd] 2 N 2 } 2− system can lose an amide ligand to provide the monoanionic [(R 2 N) 3 Nd III (μ-η 2 :η 2 -N 2 )Nd III (NR 2 ) 2 (THF)] 1− , characterized by X-ray crystallography. These data suggest a connection between the in situ Ln(III)/K reductions and Ln(II) reductions that depends on solvent, temperature, the presence of a chelate, and the specific rare-earth metal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.